3-Methylpiperidine

We are 3-Methylpiperidine CAS:626-56-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  3-Methylpiperidine
CAS.NO: 626-56-2
Synonyms:
3-methyltetrahydropyridine
3-PIPECOLINE
Hexahydro-3-picoline
3-methyl-piperidin
m-methylpiperidine
3-methyl-piperidine

Molecular Formula:C6H13N
Molecular Weight: 99.17410

Physical and Chemical Properties:
Density: 0.845 g / mL at 25 ° C (lit.)
Boiling point: 125-126 ° C763 mm Hg (lit.)
Melting point: -24 ° C
Flash point: 63 ° F
Refractive index: n20 / D 1.447 (lit.)

Specification:
Appearance: colorless to yellow liquid
Purity:≥99.0%
Water:≤0.3%
Impurity: 0.02%

Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Keep away from heat, sparks, and flame. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Corrosives area.
Application: Applicationd as an organic synthesis reagent.

3-Methylpiperidine


Related News: “We will continue to closely monitor the situation and we look forward to reopening our stores as soon as possible.”Ácido 2-imidazol-1-ilacético, hidrocloruro CAS:87266-37-3 Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.4-Chlorobenzoyl isothiocyanate Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.625-52-5 Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.

Related Products
Product Name
Divinyltetramethyldisiloxane View Details
cyclohexyl prop-2-enoate View Details
2-Amino-4,7-dihydro-5-[2-[4-(methoxycarbonyl)phenyl]ethyl]-4-oxo-3H-pyrrolo[2,3-d]pyrimidine View Details
3-fluoro-1-oxidopyridin-1-ium manufacturer 5-[1-hydroxy-2-(2,4,5-trifluorophenyl)ethylidene]-2,2-dimethyl-1,3-dioxane-4,6-dione manufacturer N-Acetyl-L-Valine manufacturer (Oxydi-2,1-phenylene)bis(diphenylphosphine) manufacturer (S)-(+)-3-Hydroxytetrahydrofuran manufacturer